Hims & Hers is accused of illegally marketing a copycat weight loss pill without the necessary SNAC technology, making their product unlikely to be effective.
Source Post
HIMS vs NVO in the battle for control over oral wegovy! #investing #finance #nvo #hims #stocks
Feb 6, 2026
The creator discusses the legal battle between Novo Nordisk (NVO) and Hims & Hers over the compounding of Wegovy. While Hims & Hers is accused of illegally marketing a copycat version, Novo Nordisk's stock (NVO) has seen a dip, which the creator views as a buying opportunity due to their proprietary SNAC technology that enables oral delivery.
Linked Mentions
Tickers discussed in this post
The creator is buying Novo Nordisk (NVO) shares on the dip, believing they will win the legal battle against Hims & Hers due to their proprietary SNAC technology for oral GLP-1 medication.